 |
Mar 21, 2012 |
|
Presentation at Drug
Discovery & Development Japan (Tokyo) on June 13,
2012
|
|
Feb 27, 2012 |
|
Consulting Agreement
with Dr. Jean-Pierre Armand, M.D., MS.c, a world authority on
cancer research field and a heavyweight in medical community
in the world, for Mebiopharm's Phase 2 clinical trial in
Europe.
|
|
Feb 20, 2012 |
|
Joint Venture
Establishment in Sri Lanka
|
|
Feb 13, 2012 |
|
Presentation at Clinical
Trials and Outsourcing
(Shanghai)
|
|
Dec 07, 2011 |
|
Joint press
conference on a joint venture in Sri Lanka (pdf in
Japanese)
|
|
Dec 07, 2011 |
|
Announcement of
establishing a joint venture in Sri Lanka (pdf in
Japanese)
|
|
Dec 06, 2011 |
|
FY Mar 2012 Interim Results
Presentation
|
|
Nov 11, 2011 |
|
Lecture in 2nd Tokyo Venture
Forum at Tokyo Stock Exchange
|
|
Oct 21, 2011 |
|
Presentation at JVCA (Japan
Venture Capital Association)
|
|
Oct 12, 2011 |
|
Presentation about "Partnering
with Japan for Clinical Trials" in Clinical Trials Asia Japan
2011 (Shanghai)
|
|
Sep 16, 2011 |
|
IR briefing session
at Phillip Securities (HK) Ltd. Branch (Hong Kong,
North Point)
|
|
Sep 15, 2011 |
|
IR briefing session
at Phillip Securities (HK) Ltd. (Hong
Kong)
|
|
Sep 14, 2011 |
|
IR briefing session at Phillip
Securities Pte Ltd (Singapore)
|
|
Sep 2, 2011 |
|
Mebiopharm analyst report by
Philip Securities Japan Ltd. (PDF)
|
|
Aug 25, 2011 |
|
Special lecture about the
listing on TOKYO AIM
|
|
Jul 28, 2011 |
|
IR briefing session at Tokyo
Stock Exchange.
|
|
Jul 15, 2011 |
|
Business plan updated(in
Japanese)
|
|
Jul 15, 2011 |
|
Announcement of
the listing on TOKYO AIM
|
|
Jul 11, 2011 |
|
Basic agreement about
Technology Transfer between Chinese Pharma (in
Japanese)
|
|
Jul 7, 2011 |
|
Suspension of new share
issues(in
Japanese)
|
|
Jul 7, 2011 |
|
Revised Specified Securities
Information uploaded(in
Japanese)
|
|
Jun 29, 2011 |
|
Revised Specified Securities
Information updated(in
Japanese)
|
|
Jun 24, 2011 |
|
Approval for listing on
TOKYO AIM
|
|
Jun 10, 2011 |
|
Application for listing on
TOKYO AIM
|
|
Jun 10, 2011 |
|
Investor Relations
updated. (in
Japanese)
|
|
Nov 10, 2010 |
|
Presentation by Dr. Jaffer
Ajani (Prof. MDAnderson Cancer Center) about of MBP-426 Phase
2 study in PSWC
2010 in New Orleans (14-18
Nov.2010).
|
|
Sep 6, 2010 |
|
Article in NIKKEI
newspaper about business collaboration with Chinese
Pharma for licensing development right in Chinese
market.
|
|
Aug 11, 2010 |
|
300million yen was invested
through a private equity placement.
|
|
Aug 10, 2010 |
|
Presentation on September 29
about Clinical Development of Anticancer Drug in
BioJapan2010.
|
|
Aug 1, 2010 |
|
"A study and development of
evaluation methods of formulation and production to build up a
scientific development strategy for drug formulation and
production" by National Institute of Health Science that
Mebiopharm takes part, is adopted as the governmental program
"Health and Labour Sciences Research Grants / Research on
Publicly Essential Drugs and Medical Devices".
|
|
Jul 15, 2010 |
|
Article about MBP-426 in
Nikkei Sangyo Shinbun
Link (only in
Japanese) |
|
May 18, 2010 |
|
Presentation at the annual
meeting of The Japan Society of Drug Delivery System
Link
(only in Japanese) |
|
Nov 18, 2009 |
|
Presentation on Phase 1b Study
result of MBP-426 at the AACR-NCI-EORTC International
Conference in Boston
Link
to the poster |
|
Sep 10, 2009 |
|
Presentation in Japan Biotech
Forum in London 2009
Link to the website
|
|
May 30, 2009 |
|
MBP-426 promising Phase I
result to be presented at ASCO 2009
Link to
the poster |
|
Feb 04, 2009 |
|
Phase II trial for 2nd line
Gastric plus GE junction starts in U.S
Nikkei
Biotech online |
|
|
|
|
|
|
|
◆ Click here to see past
articles |
